A randomized phase III study comparing standard dose BEP with sequential high-dose cisplatin, etoposide, and ifosfamide (VIP) plus stem-cell support in males with poor-prognosis germ-cell cancer. An intergroup study of EORTC, GTCSG, and Grupo Germinal (EORTC 30974)
Keyword(s):
2010 ◽
Vol 28
(15_suppl)
◽
pp. 4512-4512
◽
Keyword(s):
2003 ◽
Vol 21
(22)
◽
pp. 4083-4091
◽
Keyword(s):
2004 ◽
Vol 22
(14_suppl)
◽
pp. 4724-4724
Keyword(s):
2003 ◽
Vol 169
(4)
◽
pp. 1229-1233
◽
Keyword(s):
2002 ◽
Vol 171
(3)
◽
pp. 158-160
◽
Keyword(s):
2003 ◽
Vol 39
(6)
◽
pp. 775-782
◽
Keyword(s):
2004 ◽
Vol 22
(14_suppl)
◽
pp. 4724-4724
Keyword(s):
Keyword(s):
2005 ◽
Vol 23
(16_suppl)
◽
pp. 5006-5006
◽
Keyword(s):
2009 ◽
Vol 27
(15_suppl)
◽
pp. e16094-e16094
Keyword(s):